Ronda L. Akins

Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-Resistant <i>Staphylococcus aureus</i> , Vancomycin-Resistant <i>Enterococcus faecium</i> , and Methicillin-Resistant <i>Staphylococcus aureus</i> Isolates in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Ronda L. Akins, Michael J. Rybak · Antimicrobial Agents and Chemotherapy · 2001 · 181 citations · Full text

Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal Function

Vincent H. Tam, Peggy S. McKinnon, Ronda L. Akins et al. · Antimicrobial Agents and Chemotherapy · 2003 · 110 citations · Full text

In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant <i>Staphylococcus aureus</i> in an Infection Model

Ronda L. Akins, Michael J. Rybak · Antimicrobial Agents and Chemotherapy · 2000 · 68 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Gisa Isolates +23

Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria

Hannah M. Adams, Luke R. Joyce, Ziqiang Guan et al. · Antimicrobial Agents and Chemotherapy · 2017 · 56 citations · Full text

Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections

Susan M. Abdel‐Rahman, Gurudatt Chandorkar, Ronda L. Akins et al. · The Pediatric Infectious Disease Journal · 2011 · 52 citations

Antibiotic Adjuvant, Daptomycin 8, Pharmacotherapy +20